文献速递骨质疏松与代谢性骨病

肌肉减少症和/或骨质疏松症是否增加衰弱风险?ROAD研究第二次和第三次调查的4年观察

Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
PubMed 文献 · Osteoporos Int · 2018-06-21

本研究基于ROAD人群队列的第二次调查(2008-2010年)1083名≥60岁受试者,4年后第三次调查(2012-2013年)749人完成相同评估。衰弱患病率为5.6%,骨质疏松与衰弱发生显著相关(OR 3.07,95%CI 1.26-7.36,p=0.012);骨质疏松合并肌肉减少症者衰弱风险较两者均无者升高(OR 5.80),高于单纯骨质疏松(OR 2.50)。结论认为预防骨质疏松及骨质疏松与肌肉减少症共存可能有助于降低衰弱风险。

要点

  • 第二次调查中衰弱患病率为5.6%(男性3.8%,女性6.6%),衰弱累积发病率为1.2%/年。
  • 调整混杂因素后,骨质疏松与衰弱发生显著相关(OR 3.07,95%CI 1.26-7.36,p=0.012)。
  • 骨质疏松合并肌肉减少症者衰弱发生风险较两者均无者升高(OR 5.80),单纯骨质疏松者OR为2.50。

核心结论

  • 预防骨质疏松及骨质疏松与肌肉减少症共存可能有助于降低衰弱风险。

研究设计与样本

  • 基于ROAD人群队列研究的4年随访观察,第二次调查于2008-2010年纳入1083名≥60岁受试者(男性372名,女性711名),第三次调查于2012-2013年随访,749人完成与第二次相同的评估。
  • 衰弱采用Fried定义,肌肉减少症采用亚洲肌肉减少症工作组标准,骨质疏松采用WHO标准。

主要发现

  • 第二次调查中衰弱患病率为5.6%(男性3.8%,女性6.6%)。
  • 衰弱累积发病率为1.2%/年(男性0.8%/年,女性1.3%/年)。
  • 调整混杂因素后,骨质疏松与衰弱发生显著相关(OR 3.07,95%CI 1.26-7.36,p=0.012)。
  • 与既无骨质疏松也无肌肉减少症者相比,单纯骨质疏松者衰弱发生的OR为2.50,骨质疏松合并肌肉减少症者OR为5.80。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In this 4-year follow-up study including 1083 subjects (≥ 60 years), the prevalence of frailty was estimated to be 5.6%; osteoporosis was found to be significantly associated with frailty. Moreover, the presence of both osteoporosis and sarcopenia increased the risk of frailty compared to the presence of osteoporosis or sarcopenia alone. INTRODUCTION: This study aims to examine the contribution of sarcopenia and osteoporosis to the occurrence of frailty using 4-year follow-up information of a population-based cohort study. METHODS: The second survey of the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2008 and 2010; 1083 subjects (aged ≥ 60 years, 372 men, 711 women) completed all examinations on frailty, sarcopenia, and osteoporosis, which were defined using Fried's definition, Asian Working Group for Sarcopenia criteria, and WHO criteria, respectively. The third survey was conducted between 2012 and 2013; 749 of 1083 individuals enrolled from the second survey (69.2%, 248 men, 501 women) completed assessments identical to those in the second survey. RESULTS: The prevalence of frailty in the second survey was 5.6% (men, 3.8%; women, 6.6%). The cumulative incidence of frailty was 1.2%/year (men, 0.8%/year; women, 1.3%/year). After adjustment for confounding factors, logistic regression analysis indicated that osteoporosis was significantly associated with the occurrence of frailty (odds ratio, 3.07; 95% confidence interval, 1.26-7.36; p = 0.012). Moreover, the occurrence of frailty significantly increased according to the presence of osteoporosis and sarcopenia (odds ratio vs. neither osteoporosis nor sarcopenia: osteoporosis alone, 2.50; osteoporosis and sarcopenia, 5.80). CONCLUSIONS: Preventing osteoporosis and coexistence of osteoporosis and sarcopenia may help reduce the risk of frailty.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Yoshimura N, Muraki S, Oka H, et al. Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys. Osteoporos Int. 2018. PMID: 29931626. doi:10.1007/s00198-018-4596-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。